Results 1,041-1,060 of 11,464 for speaker:Mary Butler

Ceisteanna ó Cheannairí - Leaders' Questions (27 Jun 2024)

Mary Butler: Moore Street.

Ceisteanna ó Cheannairí - Leaders' Questions (27 Jun 2024)

Mary Butler: Where is your housing policy?

Written Answers — Department of Health: Mental Health Services (27 Jun 2024)

Mary Butler: As this is a service matter, I have asked the Health Service Executive to respond Directly to the Deputy as soon as possible.

Written Answers — Department of Health: Home Help Service (27 Jun 2024)

Mary Butler: As this is an operational matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.

Written Answers — Department of Health: Nursing Homes (27 Jun 2024)

Mary Butler: As this is an operational matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I move amendment No. 9: In page 12, after line 22, to insert the following: “PART 5 Amendment of Health (Pricing and Supply of Medical Goods) Act 2013Amendment of Health (Pricing and Supply of Medical Goods) Act 2013 11. The Health (Pricing and Supply of Medical Goods) Act 2013 is amended in section 2 — (a) in the definition of “prescriber”, by the...

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I move amendment No. 10: In page 12, after line 22, to insert the following: “PART 6 AMENDMENT OF PATIENT SAFETY (NOTIFIABLE INCIDENTS AND OPEN DISCLOSURE) ACT 2023 Amendment of Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 12. The Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 is amended— (a) in section 19(7), by the substitution...

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I thank the Deputies. I was pleased to bring these amendments forward today. As was said earlier, pharmacists are an easily accessible, highly trained and regulated valuable health resource. The value and capability they bring has been clearly evidenced in the role they played throughout the pandemic, ensuring continuity of patient care and helping to maximise access to vaccinations....

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I thank the Deputy for her amendment but at this time the Government does not propose to proceed with its inclusion. The Deputy will be aware that the Bill, as previously drafted, aimed to provide for regulations to be put in place to enable pharmacists to sell and supply certain prescription products in line with protocol, and this aimed to facilitate the sale and supply of oral...

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I have just been informed that the aim is to move the secondary legislation as soon as possible and that will include what the Deputy's ask entails. It is the aim of the Department to move that as a priority.

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: There is no timeframe.

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I move amendment No. 8: In page 12, after line 22, to insert the following: “PART 4 AMENDMENT OF PHARMACY ACT 2007 Amendment of Pharmacy Act 2007 10. The Pharmacy Act 2007 is amended— (a) in section 7(1)— (i) by the substitution of the following paragraph for paragraph (a): “(a) to regulate the profession of pharmacy in the State, including...

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I thank the Deputy. I agree with what she said about the need to maximise capacity and the strong relationship between the customer, or sometimes the patient, and the pharmacist. We normally return to the same pharmacy, especially in smaller communities. What we are referring to in the Bill currently are what we call common conditions, including some of those the Deputy referred to, such...

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: The current amendments will not facilitate the chronic disease management role. The amendment the Deputy tabled, which I think might be No. 7, was seeking on a report on the role of pharmacists in that respect.

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: It has been ruled out of order. It states, "The Minister shall, within six months of the passing of this Act, prepare and lay before Dáil Éireann a report on expanding the role of pharmacists in chronic disease management." That is where we want to get to. It is really important. At the moment, what is included in this legislation is what is called common conditions as opposed...

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: The Minister wants to take it forward, like the Deputy said, with regard to chronic illness. It is just the timing of the pharmacy taskforce considering the services offered by pharmacists in other jurisdictions. This states, "The Minister shall, within six months of the passing of this Act, prepare and lay before Dáil Éireann a report on expanding the role of pharmacists in...

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: The Minister is saying that.

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I move amendment No. 4: In page 9, to delete lines 13 to 15 and substitute the following: “(III) by the insertion of the following subparagraphs after subparagraph (iii): “(iv) subject to subsection (11A), such medicinal product or class of medicinal products as may be used for the purpose of treating mild or moderate illnesses or ailments, pursuant to a prescription...

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I move amendment No. 5: In page 9, between lines 15 and 16, to insert the following: “(b) by the insertion of the following subsection after subsection (11): “(11A) Before making regulations under section 32(2)(l)(iv) or (v), the Minister shall consult the Health Service Executive and the Council of the Pharmaceutical Society of Ireland, and may consult any other person or...

Health (Miscellaneous Provisions) Bill 2024: Report and Final Stages (26 Jun 2024)

Mary Butler: I move amendment No. 1: In page 3, to delete line 5 and substitute the following: “An Act to amend the Health Act 1970, the Irish Medicines Board Act 1995; the Pharmacy Act 2007; the Health (Pricing and Supply of Medical Goods) Act 2013 and the Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023; and to”. The amendment concerns the addition of the Patient...